You just read:

Janssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis

News provided by

Janssen Biotech

Oct 13, 2017, 16:20 ET